Arcus Biosciences (($RCUS)) announced an update on their ongoing clinical study. Arcus Biosciences is conducting a significant Phase 3 clinical ...

Regeneron Pharmaceuticals (($REGN)) announced an update on their ongoing clinical study. Regeneron Pharmaceuticals is conducting a Phase 3 ...

Actuate Therapeutics' elraglusib shows promise in metastatic pancreatic cancer. Upcoming FDA meeting may accelerate approval.

Pfizer Inc. has completed the previously announced global, ex-China, licensing agreement with 3SBio Inc., which grants Pfizer exclusive rights for the development, manufacturing and commercialization ...

Emerging therapies, including antibody-drug conjugates and biomarker-driven approaches, have the potential to significantly ...

About the RESCUE Phase 2 Clinical Trial In RESCUE, a multi-center, double-blinded, placebo-controlled, randomized Phase 2 clinical trial, Revalesio evaluated the safety and initial efficacy of RNS60.

One potential cause is lack of appropriate representation in dose-finding clinical trials. We investigated the extent of disparities in phase I clinical trials and recent changes in the setting of ...

If you plan to get an allogeneic (allo) stem cell transplant, you need someone to donate stem cells or bone marrow. Learn about the process of finding a donor.

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the initiation of the EXPrESSIVE Phase 3 clinical trials, evaluating ...

Amylyx Pharmaceuticals, Inc. today announced the presentation of new exploratory analyses from the Phase 2 PREVENT and Phase 2 b clinical trials of avexitide, an investigational, first-in-class ...

These searches identified several relevant publications, including one phase 2 trial of the long-acting amylin analogue cagrilintide and two trials of fixed-dose combination therapy with subcutaneous ...

Our team remains focused on driving enrollment and advancing this important program forward.” The MIRACLE study is a Phase 2B/3 clinical trial whereby data from the 2B portion will be combined with ...